Home » Topics » Regulatory

Regulatory
RSS

FDA approves label expansion for Harvoni

Nov. 13, 2015

FDA approves Genvoya single-tablet regimen for HIV-1

Nov. 6, 2015

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

FDA first to approve GlaxoSmithKline's Nucala

Nov. 5, 2015

FDA approves Imlygic as first oncolytic viral therapy in U.S.

Oct. 28, 2015

FDA approves Belbuca buccal film for chronic pain

Oct. 28, 2015

FDA approves Yondelis for liposarcoma and leiomyosarcoma

Oct. 26, 2015

FDA approves Merrimack's liposomal irinotecan for pancreatic cancer

Oct. 23, 2015

FDA approves Veltassa for hyperkalemia

Oct. 22, 2015

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...